BBP
$97.72 +0.79 (0.82%)
Payout Frequency

Dividend History

Pay DateAmountEx-DateRecord Date
December 27, 2017$0.072017-12-202017-12-21
December 29, 2015$0.402015-12-212015-12-23

Dividends Summary

Company News

Why Is ImmunityBio Stock Soaring On Friday?
Benzinga • Vandana Singh • March 13, 2026

ImmunityBio (IBRX) shares surged 10.60% on Friday after the company completed manufacturing engineering programs for its NK cell therapy platform. The NK2022 and NK2023 programs demonstrated safe and reproducible production of up to five billion NK cells from a single collection with no serious adverse events. Additionally, the FDA acknowledged r...

Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion
Benzinga • Lekha Gupta • April 28, 2025

Merck & Co. has agreed to acquire SpringWorks Therapeutics for around $4 billion, a 26% premium over SpringWorks' 20-day average price. The acquisition will boost Merck's revenue and expand its U.S. healthcare presence, particularly in rare tumor treatments.

Gate Q1 2025 Transparency Report: Sustained Leadership in Crypto Markets with Multiple Metrics Hitting New Highs
GlobeNewswire Inc. • Gate.Io • April 10, 2025

Gate.io, a leading global digital asset platform, has released its Q1 2025 Transparency Report, showcasing impressive growth across multiple business segments, including trading volume, token performance, security, and product offerings.

4 Best-Performing Sector ETFs of June
Zacks Investment Research • Sweta Killa • July 1, 2024

We have highlighted four top-performing ETFs from different sectors that have led the way in June.

Biotech ETFs Stage Solid Comeback at the Start of 2024
Zacks Investment Research • Sweta Killa • January 9, 2024

The biotech space staged a strong comeback at the start of 2024, driven by multi-billion dollar deals, upbeat clinical results and cutting-edge medical advances like CRISPR gene-editing hitting prime-time.

Related Companies